Cytotoxicity of cyclophosphamide, paclitaxel, and docetaxel for tumor cell lines in vitro:: effects of concentration, time and cytochrome P450-catalyzed metabolism

被引:26
作者
Gut, I [1 ]
Danielová, V [1 ]
Holubová, J [1 ]
Soucek, P [1 ]
Klucková, H [1 ]
机构
[1] Natl Publ Hlth Inst, Ctr Ind Hyg & Occupat Dis, Prague 10042 10, Czech Republic
关键词
cyclophosphamide; docetaxel; paclitaxel; cytochrome P450; cytotoxicity; apoptosis; nuclear morphology;
D O I
10.1007/s002040000141
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Cytotoxic effects of cyclophosphamide (CPA), paclitaxel (PCT), and docetaxel (DTX) and their modulation by cytochrome P450 (CYP) metabolism were studied by incubating cell lines L929 and P388D(1) with or without rat liver microsomes. The microsomes themselves were not cytotoxic. P388D(1) cells were more sensitive to CPA, PCT, and DTX than L929 cells. CYP2B1-, CYP3A-, and CYP2E1-induced microsomes effectively oxidized the prodrug CPA to cytotoxic products in 2-h incubation periods. Cytotoxicity of DTX and PCT for P388D(1) cells became apparent 24 h after 2-h incubation period with the drugs, and their effects were enhanced by CYP2E1 microsomes, but markedly decreased by CYP3A-induced microsomes. DTX and PCT without microsomes caused a dose-related cytotoxicity in P388D(1) and HeLa cells. P388D(1) and HeLa cells did not grow after a 24-h exposure to 1-10 muM DTX, but about 0.1% of cells survived exposure to 1-10 CIM PCT. After 4 weeks of multiplication, the surviving P388D(1) cells displayed lower sensitivity to DTX and PCT, but cytotoxicity in HeLa cells was unchanged and their growth ability decreased. In P388D1 cells, PCT with DTX (0.1, 0.5, 1, 2.5, or 5 muM) showed only additive cytotoxicity, although they reportedly act in different phases of the cell cycle. In P388D(1) cells treated with DTX or PCT, normal mononuclear cells disappeared and the cell diameter increased up to threefold. Mulberry-like nuclei developed, giving rise to multiple nuclei, which were hyper- or hypochromatic. Chromatin condensation in some multiple nuclei and cell shrinkage of some cells fit the definition of apoptosis, but enlargement of the surviving cells and numerous hypochromatic nuclei do not. In conclusion, L929 and P388D(1) cells incubated with microsomes enabled the role of various CYP enzymes in the effect of anticancer drugs to be assessed. The delayed cytotoxicity of DTX and PCT compared to that of CPA was related to their different mode of action. Fluorescent microscopy revealed quantitatively different effects of PCT and DTX on the nuclei, indicating that their mode of action may not be completely identical.
引用
收藏
页码:437 / 446
页数:10
相关论文
共 42 条
[1]  
ANDERSON CD, 1995, DRUG METAB DISPOS, V23, P1286
[2]   CYCLOPHOSPHAMIDE - REVIEW OF ITS MUTAGENICITY FOR AN ASSESSMENT OF POTENTIAL GERM-CELL RISKS [J].
ANDERSON, D ;
BISHOP, JB ;
GARNER, RC ;
OSTROSKYWEGMAN, P ;
SELBY, PB .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1995, 330 (1-2) :115-181
[3]  
Anderson LW, 1996, CLIN CANCER RES, V2, P1481
[4]  
BABICH H, 1990, ATLA-ALTERN LAB ANIM, V18, P129
[5]   DOCETAXEL (TAXOTERE(R)) - A REVIEW OF PRECLINICAL AND CLINICAL-EXPERIENCE .1. PRECLINICAL EXPERIENCE [J].
BISSERY, MC ;
NOHYNEK, G ;
SANDERINK, GJ ;
LAVELLE, F .
ANTI-CANCER DRUGS, 1995, 6 (03) :339-355
[6]   TOXICITY DETERMINED INVITRO BY MORPHOLOGICAL ALTERATIONS AND NEUTRAL RED ABSORPTION [J].
BORENFREUND, E ;
PUERNER, JA .
TOXICOLOGY LETTERS, 1985, 24 (2-3) :119-124
[7]  
Buege J A, 1978, Methods Enzymol, V52, P302
[8]  
CHANG TKH, 1993, CANCER RES, V53, P5629
[9]  
Chen L, 1996, CANCER RES, V56, P1331
[10]  
CRESTEIL T, 1994, CANCER RES, V54, P386